necessary FBLD technologies
facets of FBLD
FBLD work
FBLD research area
dedicated FBLD training network
prominent pharmaceutical companies
pharmaceutical sciences
necessary training
academic research groups
academic groups
combined technologies
media training
hit fragment
efficient lead discovery
specialised biotech companies
fragment-based lead discovery
todayâ€™s drug discovery
biophysical screening technologies
ESRs
FragNet
low affinity binding of low molecular weight compounds
detailed understanding
optimised compounds
drug development
so-called fragments
molecular interactions
protein targets
efficient optimisation
target protein
binding event
thorough understanding of scientific knowledge transfer
chemical biology programmes
entrepreneurship
enthusiasm
writing
high quality leads
transferable skill sets
promise
SMEs
multidisciplinary nature
possibilities
opportunities
interface of chemistry
private organisations
approaches
skills
holistic view
pathophysiological processes
consortium
institute
present